학술논문
Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection.
Document Type
Article
Author
Urbanowicz, Richard A.; Tsoleridis, Theocharis; Jackson, Hannah J.; Cusin, Lola; Duncan, Joshua D.; Chappell, Joseph G.; Tarr, Alexander W.; Nightingale, Jessica; Norrish, Alan R.; Ikram, Adeel; Marson, Ben; Craxford, Simon J.; Kelly, Anthony; Aithal, Guruprasad P.; Vijay, Amrita; Tighe, Patrick J.; Ball, Jonathan K.; Valdes, Ana M.; Ollivere, Benjamin J.
Source
Science Translational Medicine; 9/1/2021, Vol. 13 Issue 609, p1-9, 9p
Subject
Language
ISSN
19466234
Abstract
Copyright of Science Translational Medicine is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)